The EGFR pathway contributes to pancreatic cancer growth and accelerates invasion of the cancer as a result of lnc00976 overexpression, which can deteriorate the outcome of patients [69, 70]. This evidence concerns the gene EGFR and familial pancreatic carcinoma.